Profit Margin (Quarterly) Chart

Historical Profit Margin (Quarterly) Data

View and export this data back to 2013. Start Trial.
Date Value
May 31, 2026 -184.8K%
February 28, 2026 -63.69K%
November 30, 2025 -19.99K%
August 31, 2025 -246.5K%
May 31, 2025
February 28, 2025 -52.50K%
November 30, 2024 -143.2K%
August 31, 2024 -278.5K%
May 31, 2024 -76.67K%
February 29, 2024 -113.0K%
November 30, 2023 -96.78K%
August 31, 2023 -29.28K%
May 31, 2023 -13.92K%
February 28, 2023 -22.00K%
November 30, 2022 -15.60K%
August 31, 2022 -61.74K%
May 31, 2022 -4.57K%
February 28, 2022 -3.89K%
November 30, 2021 -120.5K%
August 31, 2021 -53.28K%
May 31, 2021 -23.82K%
February 28, 2021
November 30, 2020
August 31, 2020 -17.38K%
May 31, 2020 -7.41K%
Date Value
February 29, 2020
November 30, 2019 -5.73K%
August 31, 2019 -3.96K%
May 31, 2019 -836.7%
February 28, 2019 -10.72K%
November 30, 2018 -3.27K%
August 31, 2018 -13.03K%
May 31, 2018 -36.92K%
February 28, 2018 -56.20K%
November 30, 2017 -1.84K%
August 31, 2017 -2.06K%
May 31, 2017 -6.83K%
February 28, 2017 -13.67K%
November 30, 2016 -993.1%
August 31, 2016 -2.85K%
May 31, 2016 -16.29K%
February 29, 2016 -1.64K%
November 30, 2015 -2.26K%
August 31, 2015 -3.67K%
May 31, 2015 -4.22K%
February 28, 2015 -2.97K%
November 30, 2014 -6.78K%
August 31, 2014 -2.06K%
May 31, 2014 -10.76K%
February 28, 2014 -5.44K%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Hansa Biopharma AB -541.7%
BioArctic AB -4.51%
Swedish Orphan Biovitrum AB 14.00%
BONESUPPORT HOLDING AB 23.02%
BioInvent International AB -964.0%

Profit Margin (Quarterly) Related Metrics